Magazine

Table: Nuking Cancer


Two new drugs use antibodies to deliver radiation directly to the tumor cell.

ZEVALIN

Combines antibody with yttrium-90 for treatment of non-Hodgkin's lymphoma

Maker: IDEC Pharmaceuticals

Status: Recommended by FDA advisory panel on Sept. 11

BEXXAR

Antibody combined with iodine-131, also for non-Hodgkin's

Maker: Corixa/GlaxoSmithKline

Status: Completed FDA application filing on Sept. 7


Best LBO Ever
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus